Under normal circumstances, CD4+ and CD8+ T cells should be responsible for initiating anti-tumorigenic immunity, but they are exhausted by the surrounding tumor microenvironment via upregulating PD-1 receptors [205,206]. The gene discussed is CD4; the disease is neoplasm.